Search.co

The global MedTech market is closing in on $695 billion — and the forces pushing it there aren't going away. This episode breaks down the structural drivers, margin pressures, and M&A strategies reshaping the industry's competitive landscape.

Show Notes

At nearly $695 billion and still climbing, the global medical-technology market is one of the most consequential growth stories in the world economy — and one of the most nuanced. This episode of Search.co draws on the MedTech industry market research report to go beyond the headline number, unpacking why the sector is growing, where the pressure points are hiding, and what the strategic winners are doing differently.

Here's what the episode covers:

  • The scale of the opportunity: MedTech grew from roughly $668 billion in 2024 toward a projected $695 billion in 2026 — a ~4% annual clip that, at this size, represents enormous absolute value creation, with some forecasts pointing past $850 billion by the early 2030s.
  • Three structural growth drivers: Aging global demographics generating sustained demand for cardiovascular, diabetes, and neurological devices; a wave of high-margin innovations (surgical robotics, AI-enabled imaging, pulsed-field ablation); and rapidly expanding hospital infrastructure across Asia, Latin America, and the Middle East opening entirely new geographies.
  • The margin paradox: Despite strong top-line growth, sector profit margins have slipped below 2019 levels — squeezed by tariffs, logistics disruption, and the compliance burden of the EU's Medical Device Regulation. Only about a quarter of firms managed above-average profitability growth in recent years.
  • An M&A wave with a clear message: Around 195 acquisitions totaling ~$47 billion closed in 2024 alone. Marquee deals — Johnson & Johnson's ~$13 billion Shockwave Medical buy, Boston Scientific's ~$3.7 billion Axonics acquisition — signal that organic growth alone can't secure the next generation of market position.
  • The ecosystem imperative: Leading companies are moving beyond hardware, layering software and services onto their device franchises to raise switching costs and extend revenue relationships — a model borrowed from software and now being executed at MedTech scale. AI-powered data analysis is central to building these integrated, data-driven care platforms.
  • Valuation signals: The sector trades at 14–22× EV/EBITDA; cardiovascular, robotics, and diabetes franchises command the upper end of the range, while more commodity-exposed names cluster lower — a clear market signal about where durable value is being created.

For researchers and analysts tracking these dynamics, competitive intelligence capabilities are increasingly essential for monitoring deal flow, innovation pipelines, and shifting margin profiles across MedTech's many sub-segments. More from the show: listen to From Raw Web Data to Real Intelligence: Inside the Search.co Stack for a deeper look at how structured data powers industry research like this.

Search.co

What is Search.co?

AI-assisted market research — how to ask a question you can actually act on, and how to know when the answer is trustworthy. Sizing a market, reading a competitive landscape, designing research that survives scrutiny, and where AI genuinely speeds the work versus where it quietly invents things.

Each episode takes one research problem and works through method: what evidence would change your mind, which sources to weight, how to present a finding your leadership will believe. Written for strategy, product and marketing teams who have to decide something. Five or six minutes, one method at a time.

Topics include market sizing you can defend, competitive landscape mapping, survey and interview design, source weighting and verification, synthesising findings leadership will believe, and where AI accelerates research versus where it fabricates.

Produced by Search.co, AI-powered market research. Full details, services and further reading at https://search.co